Pages that link to "Q36367821"
The following pages link to Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo. (Q36367821):
Displaying 32 items.
- The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis (Q28591104) (← links)
- Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation (Q30845162) (← links)
- Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis (Q33728430) (← links)
- Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy (Q34412294) (← links)
- Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice (Q35615758) (← links)
- IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. (Q35757368) (← links)
- IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytoma (Q35799158) (← links)
- Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. (Q35848463) (← links)
- CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes (Q35983806) (← links)
- Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma. (Q36004284) (← links)
- Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells (Q36370130) (← links)
- B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. (Q36370918) (← links)
- Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. (Q36371632) (← links)
- B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo (Q36376380) (← links)
- Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells (Q36404025) (← links)
- Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40. (Q36440066) (← links)
- De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. (Q36459332) (← links)
- Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion (Q36801213) (← links)
- Neoantigen: A Long March toward Cancer Immunotherapy (Q36963359) (← links)
- Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory. (Q37102329) (← links)
- The development and functions of CD4(+) T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope (Q37728225) (← links)
- Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies (Q38945576) (← links)
- Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs (Q39713047) (← links)
- Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes (Q39752699) (← links)
- Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. (Q40060440) (← links)
- Ectopic T cell receptor expression causes B cell immunodeficiency in transgenic mice. (Q44781046) (← links)
- T cell deficiency leads to liver carcinogenesis in azoxymethane-treated rats. (Q53350855) (← links)
- Eradication of established tumors by CD8+ T cell adoptive immunotherapy (Q74301350) (← links)
- Priming of naive T cells inside tumors leads to eradication of established tumors (Q75221014) (← links)
- Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity (Q82401925) (← links)
- Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells (Q92740937) (← links)
- Neoantigen vaccine: an emerging tumor immunotherapy (Q92827446) (← links)